Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 113

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 1
Chunk 113
---
 subject to various other anti-bribery and
anti-money laundering laws in the countries in which we conduct activities. Anti-corruption and anti-bribery laws have
been enforced aggressively in recent years and broadly prohibit companies, their employees and third-party intermediaries to
authorize, offer or provide, directly or indirectly, improper payments or benefits to recipients in the public or private sector. As we
increase our international sales and business, we may engage with business partners and third-party intermediaries to market our
products and to obtain necessary permits, licenses, and other regulatory approvals. In addition, we or our third-party intermediaries
may have direct or indirect interactions with officials and employees of government agencies or state-owned or -affiliated entities.
We could be held liable for the corrupt or other illegal activities of these third-party intermediaries, our employees, representatives,
contractors, partners, and agents, even if we do not explicitly authorize such activities.

Various laws, regulations and executive orders also restrict the use
and dissemination outside of the United States, or the sharing with certain non-U.S. nationals, of information products classified
for national security purposes, as well as certain products, technology and technical data relating to those products. If we expand our
presence outside of the United States, it will require us to dedicate additional resources to comply with these laws, and these laws
may preclude us from developing, manufacturing, or selling certain products and product candidates outside of the United States,
which could limit our growth potential and increase our development costs.

The failure to comply with laws governing international business practices
may result in substantial civil and criminal penalties and suspension or debarment from government contracting. The SEC also may suspend
or bar issuers from trading securities on U.S. exchanges for violations of the FCPA’s accounting provisions.

Risks Related to the Development of the Company’s Product
Candidates

The following risk factors reference the risks and uncertainties
relating to the development of product candidates by OSR, which, following the closing of the Business Combination, will be the development of
product candidates by the Company. References in this section to “we,” “us,” and “our” refer to OSR
prior to the closing of the Business Combination and to the Company after closing.

Our business includes subsidiaries that are developing oral immunotherapies
for the treatment of cancer and design-augmented